'Govt allowing this to happen': Supreme Court questions overpricing of medicines, massive gap in MRP and cost to retailers
Hindustan Times

The SC bench questioned why the system appeared to favour pharmaceutical manufacturers and asked whether such practices should be allowed to continue unchecked
Summary from Hindustan Times
Read the full story on Hindustan TimesFollow










